Viatris (VTRS) Change in Acquisitions & Divestments (2020 - 2026)
Viatris (VTRS) posted Change in Acquisitions & Divestments of $400.0 million for Q1 2026, up 6796.55% on a QoQ basis from $5.8 million in Q4 2025, and up 8595.65% year-over-year from $4.6 million in Q1 2025.
Analysis
Viatris (VTRS) Change in Acquisitions & Divestments (2020 - 2026) Analysis & Trends
Viatris has reported Change in Acquisitions & Divestments for 7 years, with the latest figure at $400.0 million in Q1 2026.
- On a quarterly basis, Change in Acquisitions & Divestments rose 8595.65% year-over-year to $400.0 million in Q1 2026; TTM through Jun 2026 was $413.0 million, a 1650.0% increase from a year earlier, with the FY2025 full-year figure at $23.9 million, down 8.08% from the prior year.
- Change in Acquisitions & Divestments was $400.0 million for Q1 2026 at Viatris, up from $5.8 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $400.0 million in Q1 2026, with the low at $4.3 million in Q3 2023.
- Average Change in Acquisitions & Divestments over 5 years is $29.8 million, with a median of $6.9 million recorded in 2022.
- The sharpest annual moves came in 2023 and 2026: Change in Acquisitions & Divestments sank 57.84% in 2023, then surged 8595.65% in 2026.
- Over 5 years, Change in Acquisitions & Divestments stood at $6.9 million in 2022, then decreased by 21.74% to $5.4 million in 2023, then fell by 20.37% to $4.3 million in 2024, then surged by 34.88% to $5.8 million in 2025, then surged by 6796.55% to $400.0 million in 2026.
- The last three Change in Acquisitions & Divestments figures came in at $400.0 million (Q1 2026), $5.8 million (Q4 2025), and $7.2 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 400.00 Mn |
| Dec 31, 2025 | 5.80 Mn |
| Sep 30, 2025 | 7.20 Mn |
| Jun 30, 2025 | 6.30 Mn |
| Mar 31, 2025 | 4.60 Mn |
| Dec 31, 2024 | 4.30 Mn |
| Sep 30, 2024 | 8.40 Mn |
| Jun 30, 2024 | 5.60 Mn |
| Mar 31, 2024 | 7.70 Mn |
| Dec 31, 2023 | 5.40 Mn |
| Sep 30, 2023 | 4.30 Mn |
| Jun 30, 2023 | 7.60 Mn |
| Mar 31, 2023 | 9.00 Mn |
| Dec 31, 2022 | 6.90 Mn |
| Sep 30, 2022 | 10.20 Mn |
| Jun 30, 2022 | 4.30 Mn |
| Mar 31, 2022 | 8.50 Mn |
| Dec 31, 2021 | 3.80 Mn |
| Sep 30, 2021 | 6.80 Mn |
| Jun 30, 2021 | 6.90 Mn |